Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms - PubMed (original) (raw)
Comparative Study
Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms
J A Curci et al. J Vasc Surg. 2000 Feb.
Free article
Abstract
Purpose: Matrix metalloproteinases (MMPs) are considered to play a central role in the pathogenesis of abdominal aortic aneurysms (AAAs). Doxycycline (Dox) has direct MMP-inhibiting properties in vitro, and it effectively suppresses the development of elastase-induced AAAs in rodents. The purpose of this study was to determine if treatment with Dox suppresses MMPs within human aneurysm tissue and to elucidate the molecular mechanisms underlying this effect.
Methods: Aneurysm tissues were obtained from 15 patients with an AAA, eight of whom had been treated with Dox before surgery (100 mg orally twice a day for 7 days). Protein extracts were examined by means of gelatin zymography and immunoblot analysis, and RNA was examined by means of reverse transcription-polymerase chain reaction (RT-PCR). The effects of Dox on MMP production were further examined in human THP-1 mononuclear phagocytes in vitro.
Results: No detectable difference was found between groups by using substrate zymography as a means of assessing total MMP activity, but Dox treatment was associated with a slight (24.4%) reduction in the activated fraction of 72-kDa gelatinase (MMP-2; P <.05). In contrast, a 2.5-fold reduction in the amount of extractable 92-kDa gelatinase (MMP-9) protein in Dox-treated patients was revealed by means of immunoblot analysis (P <.05). Also, a 5.5-fold (81.9%) reduction in MMP-9 messenger RNA (mRNA) in Dox-treated patients was demonstrated by means of quantitative competitive RT-PCR (mean +/- SE, mol MMP-9/mol beta-actin: 1.3 +/- 0.5 vs 7.2 +/- 3.1; P <.04). There was no significant difference between groups in the relative expression of MMP-2 protein or mRNA. In cultured THP-1 monocytes stimulated with phorbol ester, the expression of MMP-9 protein and mRNA were both decreased after exposure to relevant concentrations of Dox in vitro.
Conclusion: In addition to its recognized effects as a direct MMP antagonist, Dox may influence connective tissue degradation within human aneurysm tissue by reducing monocyte/macrophage expression of MMP-9 mRNA and by suppressing the post-translational processing (activation) of proMMP-2. Through this complementary combination of mechanisms, treatment with Dox may be a particularly effective strategy for achieving MMP inhibition in patients with an AAA.
Similar articles
- MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Thompson RW, Baxter BT. Thompson RW, et al. Ann N Y Acad Sci. 1999 Jun 30;878:159-78. doi: 10.1111/j.1749-6632.1999.tb07682.x. Ann N Y Acad Sci. 1999. PMID: 10415728 - Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Abdul-Hussien H, Hanemaaijer R, Verheijen JH, van Bockel JH, Geelkerken RH, Lindeman JH. Abdul-Hussien H, et al. J Vasc Surg. 2009 Mar;49(3):741-9. doi: 10.1016/j.jvs.2008.09.055. J Vasc Surg. 2009. PMID: 19268776 Clinical Trial. - Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.
Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW. Curci JA, et al. J Vasc Surg. 1998 Dec;28(6):1082-93. doi: 10.1016/s0741-5214(98)70035-7. J Vasc Surg. 1998. PMID: 9845660 - Clonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice?
Kroon AM, Taanman JW. Kroon AM, et al. Int J Mol Sci. 2015 May 18;16(5):11178-95. doi: 10.3390/ijms160511178. Int J Mol Sci. 2015. PMID: 25993290 Free PMC article. Review. - An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms.
Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML. Keeling WB, et al. Vasc Endovascular Surg. 2005 Nov-Dec;39(6):457-64. doi: 10.1177/153857440503900601. Vasc Endovascular Surg. 2005. PMID: 16382266 Review.
Cited by
- The effect of exercise training intervention for patients with abdominal aortic aneurysm on cardiovascular and cardiorespiratory variables: an updated meta-analysis of randomized controlled trials.
Han Q, Qiao L, Yin L, Sui X, Shao W, Wang Q. Han Q, et al. BMC Cardiovasc Disord. 2024 Jan 30;24(1):80. doi: 10.1186/s12872-024-03745-x. BMC Cardiovasc Disord. 2024. PMID: 38291355 Free PMC article. - Novel pharmacological approaches in abdominal aortic aneurysm.
Puertas-Umbert L, Almendra-Pegueros R, Jiménez-Altayó F, Sirvent M, Galán M, Martínez-González J, Rodríguez C. Puertas-Umbert L, et al. Clin Sci (Lond). 2023 Aug 14;137(15):1167-1194. doi: 10.1042/CS20220795. Clin Sci (Lond). 2023. PMID: 37559446 Free PMC article. Review. - Effect of Two Years of Doxycycline Treatment on Infrarenal Aortic Neck Diameter.
Panthofer AM, Olson SL, Rademacher BL, Kraiss LW, Blackwelder WC, Baxter BT, MacTaggart JN, Katzen BT, Berman SS, Matsumura JS; N-TA3CT investigators. Panthofer AM, et al. EJVES Vasc Forum. 2023 May 24;59:43-48. doi: 10.1016/j.ejvsvf.2023.05.011. eCollection 2023. EJVES Vasc Forum. 2023. PMID: 37408850 Free PMC article. - Development of pharmacotherapies for abdominal aortic aneurysms.
Weaver LM, Loftin CD, Zhan CG. Weaver LM, et al. Biomed Pharmacother. 2022 Sep;153:113340. doi: 10.1016/j.biopha.2022.113340. Epub 2022 Jun 30. Biomed Pharmacother. 2022. PMID: 35780618 Free PMC article. Review. - AAA Revisited: A Comprehensive Review of Risk Factors, Management, and Hallmarks of Pathogenesis.
Kessler V, Klopf J, Eilenberg W, Neumayer C, Brostjan C. Kessler V, et al. Biomedicines. 2022 Jan 2;10(1):94. doi: 10.3390/biomedicines10010094. Biomedicines. 2022. PMID: 35052774 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous